Closed-Loop Neuromodulation for Intractable Epilepsy

This technology presents a sophisticated closed-loop neuromodulation method targeting the pulvinar thalamic nucleus using high-frequency burst activity markers to effectively manage medically refractory epilepsy.

Description

The technology constitutes a method for treating medically refractory epilepsy through closed-loop neuromodulation focused on the pulvinar nucleus of the thalamus. The method involves the implantation of electrodes within the pulvinar region to enable precise recording of neural activity. By analyzing electrophysiological data, specifically identifying regions characterized by elevated high-frequency burst activity, clinicians can determine optimal stimulation targets. The electrical stimulation, delivered via deep brain stimulation (DBS) protocols, utilizes parameters tailored to modulate neural activity in a manner that mitigates epileptogenic discharges without relying solely on anatomical landmarks for targeting. This patient-specific approach enables dynamic adjustments to stimulation targets and parameters, enhancing therapeutic effectiveness. Additionally, the technology integrates procedural methodologies including stereotactic surgical techniques for accurate electrode placement and post-operative monitoring to assess neural responses and seizure frequency. The flexibility of this method allows its application in both focal and generalized epilepsy cases, designed to complement anti-epileptic drug regimens and potentially interface with rehabilitation programs to support long-term neurological recovery.

Applications

- Treatment of medically refractory focal epilepsy particularly in cases where seizures originate from eloquent cortical areas contraindicating surgical resection.
- Management of generalized epilepsy by modulating thalamic circuitry implicated in seizure propagation.
- Use in adjunct with pharmacological treatments to enhance seizure control efficacy.
- Integration into patient-specific therapeutic regimens through electrophysiological mapping, allowing personalized neuromodulation strategies.
- Application in closed-loop neuromodulation devices designed to detect pathological neural activity and dynamically adjust stimulation in real time.
- Support of post-operative rehabilitation protocols aimed at optimizing neurological function and quality of life.

Advantages

- Precision Targeting: Utilizes electrophysiological biomarkers, specifically high-frequency burst patterns, to identify optimal stimulation sites, offering a more accurate and individualized approach than solely anatomy-based targeting.
- Closed-loop Modulation: Enables responsive stimulation that adapts in real time to neural activity, improving efficacy and reducing unnecessary stimulation.
- Non-destructive Alternative: Provides an option to surgical resection, reducing risks associated with removing critical brain tissue in eloquent areas.
- Complementary Therapy: Designed to work alongside existing anti-epileptic drug treatments, enhancing the overall therapeutic landscape for refractory epilepsy.
- Scalable Application: Applicable to both focal and generalized epilepsy types, broadening potential patient benefit.
- Technical Integration: Incorporates advanced stereotactic implantation and postoperative monitoring for continual assessment and optimization of therapy.
- Potential for Rehabilitation Synergy: Can be integrated with rehabilitative efforts to improve patient outcomes beyond seizure reduction, addressing neurological function and recovery.

Invention Readiness

The technology has established a valid proof of concept for selecting pulvinar subregions based on high-frequency and multi-unit burst activity to reduce epileptiform features. Experimental data demonstrates that targeting these high-burst areas correlates with the greatest reduction in epileptogenic activity during stimulation. To advance this technology toward commercial readiness, further clinical studies are needed to evaluate the long-term safety, chronic efficacy, and precise parameters of the closed-loop stimulation across a larger patient demographic.

IP Status

Patent Pending

Related Publication(s)

Damiani, A., Nouduri, S., Ho, J.C. et al. Thalamocortical hodology to personalize electrical stimulation for focal epilepsy. Nat Commun 16, 9209 (2025). https://doi.org/10.1038/s41467-025-64922-w